论文信息 - Long-term outcome of phase I/II clinical trial of Ad-OC-TK/VAL gene therapy for hormone-refractory metastatic prostate cancer. - 字舞流文

Long-term outcome of phase I/II clinical trial of Ad-OC-TK/VAL gene therapy for hormone-refractory metastatic prostate cancer.

K. Sugimura | L. Chung | K. Hamada | A. Gotoh | C. Kao | N. Hinata | T. Shirakawa | M. Fujisawa | S. Kamidono | E. Higashihara | T. Okegawa | Kazushi Tanaka | T. Gardner | A. Takenaka | I. Hara | K. Fuji | S. Terao | M. Matsuo | Masafumi Matsuo